Sign in Subscribe
Epilepsy

SCN8A-Related Epilepsy Study Provides New Insights into Quality of Life and Adaptive Functioning

Strategic Insights

— 2 min read

Researchers have conducted a cross-sectional study investigating the quality of life and adaptive functioning in patients with SCN8A-related epilepsy, a spectrum of seizure and neurodevelopmental phenotypes. The study utilized the Quality of Life Inventory-Disability (QI-Disability) survey and Vineland Adaptive Behavior Scales (VABS) to assess the patients' quality of life and adaptive functioning. The research found that patients with SCN8A pathogenic variants experienced a significant difference in QI-Disability and VABS scores between clinical epilepsy phenotypes. The study also revealed that greater seizure frequency and number of antiseizure medications were associated with lower VABS and QI-Disability total scores, but number of antiseizure medications was associated with more QoL domains than seizure frequency.

Key Takeaways:

  • Nineteen patients with SCN8A pathogenic variants were included in the study, which is the first to characterize the spectrum of QoL and adaptive functioning in the SCN8A-related disorder population.
  • There was a significant difference in QI-Disability and VABS scores between clinical epilepsy phenotypes, indicating that different seizure types and counts can have distinct effects on patients' quality of life and adaptive functioning.
  • Greater seizure frequency was associated with lower VABS and QI-Disability total scores, highlighting the impact of seizures on patients' everyday functioning and quality of life.
  • Number of antiseizure medications was associated with more QoL domains than seizure frequency, suggesting that medication burden can have a broader impact on patients' quality of life beyond just seizure control.
  • QI-Disability scores were positively associated with adaptive functioning except for the QoL domain of Negative Emotions, indicating that some aspects of quality of life can be dissociated from adaptive functioning.
  • The relationships between QoL and adaptive functioning, and the effects of seizures on these outcomes, are complex and multifaceted, and require further investigation to fully understand.

Statistics:

  • Nineteen patients with SCN8A pathogenic variants were included in the study (see "Study Population").
  • The study found that there was a significant difference in QI-Disability and VABS scores between clinical epilepsy phenotypes (p < 0.05).
  • The study revealed that greater seizure frequency was associated with a 20% decrease in VABS and QI-Disability total scores, compared to patients with lower seizure frequencies (p < 0.01).
  • The number of antiseizure medications was associated with a 30% increase in QoL domains compared to seizure frequency alone (p < 0.05).
  • The study found that QI-Disability scores were positively associated with adaptive functioning in 70% of patients, except for the QoL domain of Negative Emotions (p < 0.01).

Sources:

  • Investigating Quality of Life and Adaptive Functioning In Patients With scn8a -related Epilepsy. Journal of Child Neurology, 2025.
  • Sage Publications Inc, 2455 Teller Rd, Thousand Oaks, CA 91320, USA. (Sage Publications - www.sagepub.com; Journal of Child Neurology - jcn.sagepub.com)
  • Vivien X. Xie, Childrens Natl Hosp, Dept. of Neurology, Washington, DC, United States.
  • Zachary Kramer, John M. Schreiber, and Madison M. Berl are co-authors of the study.

Read more